Pigmented progressive purpuric dermatosishttps://en.wikipedia.org/wiki/Pigmented_purpuric_dermatosis
Pigmented progressive purpuric dermatosis e bolela maemo a letlalo a sa hlohloneng a bonahalang ka ho phatloha ha letlalo la purpuric. Boholo ba leqeba bo tloha ho 0,3 ho isa ho 1 cm, 'me hangata bo bonoa likarolong tse tlaase. Setlolo sa cortisone se tla thusa ho hlohlona le ho ntlafatsa ho fifala ha letlalo. Pigmented progressive purpuric dermatosis ha e bake matšoao a mang ntle le ho fifala ha letlalo. Maqeba a hlaha hangata maotong a tlase, empa a ka hlaha kae kapa kae 'meleng, ho kenyelletsa matsoho, matsoho, torso esita le molala.

Kalafo - Lithethefatsi tsa OTC
OTC steroid mafura
#Hydrocortisone ointment
#Hydrocortisone cream
☆ Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine.
  • Schamberg disease ― monna ea lilemo li 26 ea nang le patch ea asymptomatic pigmentation le telangiectasia leotong.
    References Pigmented Purpuric Dermatoses: A Complete Narrative Review 34070260 
    NIH
    Pigmented purpuric dermatoses (PPD) ke sehlopha sa maemo a letlalo a tšoauoang ke libaka tse nyane tsa ho tsoa mali tlasa letlalo ka lebaka la ho ruruha ha capillary. PPD hangata e qala e le matheba a mafubelu ho isa ho a pherese ao hamorao a fetohang bosootho ba khauta ha hemosiderin e ntse e monngoa hape.
    Pigmented purpuric dermatoses (PPD) include several skin diseases characterized by multiple petechial hemorrhage as consequence of capillaritis. PPD generally present with red to purple macules that progressively evolve to golden-brown color as the hemosiderin is reabsorbed.
     Schamberg Disease 32809367 
    NIH
    Schamberg disease ke mofuta o tsebahalang haholo oa pigmented purpuric dermatoses (PPDs) , e leng maemo a sa foleng a letlalo a khetholloang ke matheba a manyane a khubelu kapa a pherese, le ho eketseha ha 'mala oa letlalo (mabala a sootho, a khubelu kapa a mosehla) . Li-PPD li arotsoe ka mefuta e mehlano: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura, eczematoid-like purpura of Doucas and Kapetanakis. Schamberg disease (SD) e boetse e tsejoa e le progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressiva, Schamberg's purpura. E ama haholo banna 'me hangata e hlaha maotong a tlase, empa e ka hlaha le liropeng, liropeng, kutung kapa matsohong.
    Schamberg disease represents the most common type of pigmented purpuric dermatoses (PPDs), a chronic, benign, cutaneous eruptions characterized by petechiae, purpura, and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into five clinical entities: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura and, eczematoid-like purpura of Doucas and Kapetanakis. Schamber disease (SD) has also been called: progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive and, Schamberg's purpura. It is commonly seen in males and mainly affects the tibial regions, and could involve thighs, buttocks, trunk, or upper extremities.
     Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis 26273156 
    NIH
    Litaba tse mabapi le bakuli ba 113 ba nang le PPD li ile tsa hlahlojoa, ho kenyelletsa le ba 38 ba ileng ba etsoa tlhahlobo ea letlalo bakeng sa thuto ena. Mofuta o tloaelehileng oa kliniki e ne e le lefu la Schamberg (60. 5%) . Maemo a mang haufi le PPD e ne e le khatello ea mali (15. 8%) , lefu la tsoekere (10. 5%) , le tse ling. Litlaleho tsa meriana li senotse li-statins (13. 2%) , beta blockers (10. 5%) , le tse ling. Lintho tse ka 'nang tsa amahanngoa le PPD li ne li kenyelletsa tšoaetso ea morao tjena ea ho hema ka holimo (5. 3%) , ho ema nako e telele ho lebisang khatellong e phahameng ea orthostatic (2. 6%) , le boikoetliso bo matla (2. 6%) . Kalafo e ile ea fuoa bakuli ba 36 (94. 7%) - oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.
    Information on 113 patients with PPD was analyzed, and 38 subjects with skin biopsy were included for this study. Schamberg's disease was the most frequent clinical type (60.5%). Concomitant diseases included hypertension (15.8%), diabetes (10.5%), and others. Associated medication histories included statins (13.2%), beta blockers (10.5%), and others. Possibly associated etiologic factors were recent upper respiratory infection (5.3%), high orthostatic pressure due to prolonged standing (2.6%), and strenuous exercise (2.6%). A total of 36 patients (94.7%) were treated with one or more treatment methods, including oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.